Process Optimization and DOE Application in the Synthesis of Rociletinib Intermediate
Critical step of Rociletinib synthesis, regioselective nucleophilic aromatic substitution of C-2 chlorine at pyrimidine molecule 3 with amine 2, was optimised by implementation of pre-DoE screening and DoE-based algorithms. The synthesis reaction was developed and optimised by following a quality b...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Croatian Society of Chemical Engineers
2018-07-01
|
| Series: | Chemical and Biochemical Engineering Quarterly |
| Subjects: | |
| Online Access: | http://silverstripe.fkit.hr/cabeq/assets/Uploads/02-2-18.pdf |
| _version_ | 1819294986790764544 |
|---|---|
| author | S. Kapić I. Nekola F. Jović M. Mihovilović |
| author_facet | S. Kapić I. Nekola F. Jović M. Mihovilović |
| author_sort | S. Kapić |
| collection | DOAJ |
| description | Critical step of Rociletinib synthesis, regioselective nucleophilic aromatic substitution of C-2 chlorine at pyrimidine molecule 3 with amine 2, was optimised by implementation of pre-DoE screening and DoE-based algorithms. The synthesis reaction was developed
and optimised by following a quality by design (QbD) approach, whereby a control strategy was developed for enhanced level of quality assurance. Optimisation of three main parameters (volume of solvent mixture, solvent ratio, and NaOAc quantity) resulted with good isomer ratio of over 8:1 with respect to desired C-2 isomer 4 with minimum of di-substituted impurity 6. The crude product was, however, contaminated with Zn-based inorganics and had to be recrystallized to achieve acceptable purity and
assay. Interaction of process variables and their corresponding effects on the percent conversion of maleic acid were discussed. Consistency of statistical model was verified by analysis of variance (ANOVA). API quality specifications (purity, impurity levels) are described across the modelling of process space, which was defined through quality target specifications (conversion NLT 70 %; Product Compound 4 NLT 50 %, Impurity 5
NMT 20 %, and Impurity 6 NMT 0.5). |
| first_indexed | 2024-12-24T04:35:02Z |
| format | Article |
| id | doaj.art-895c2e44f7324027a6b6630d70b215bf |
| institution | Directory Open Access Journal |
| issn | 0352-9568 1846-5153 |
| language | English |
| last_indexed | 2024-12-24T04:35:02Z |
| publishDate | 2018-07-01 |
| publisher | Croatian Society of Chemical Engineers |
| record_format | Article |
| series | Chemical and Biochemical Engineering Quarterly |
| spelling | doaj.art-895c2e44f7324027a6b6630d70b215bf2022-12-21T17:15:14ZengCroatian Society of Chemical EngineersChemical and Biochemical Engineering Quarterly0352-95681846-51532018-07-0132216717510.15255/CABEQ.2017.1200Process Optimization and DOE Application in the Synthesis of Rociletinib IntermediateS. Kapić0I. Nekola1F. Jović2M. Mihovilović3Pliva Croatia LTD, TAPI Croatia, TAPI R&D, Prilaz baruna Filipovića 25, 10000 Zagreb, CroatiaPliva Croatia LTD, TAPI Croatia, TAPI R&D, Prilaz baruna Filipovića 25, 10000 Zagreb, CroatiaPliva Croatia LTD, TAPI Croatia, TAPI R&D, Prilaz baruna Filipovića 25, 10000 Zagreb, CroatiaPliva Croatia LTD, TAPI Croatia, TAPI R&D, Prilaz baruna Filipovića 25, 10000 Zagreb, CroatiaCritical step of Rociletinib synthesis, regioselective nucleophilic aromatic substitution of C-2 chlorine at pyrimidine molecule 3 with amine 2, was optimised by implementation of pre-DoE screening and DoE-based algorithms. The synthesis reaction was developed and optimised by following a quality by design (QbD) approach, whereby a control strategy was developed for enhanced level of quality assurance. Optimisation of three main parameters (volume of solvent mixture, solvent ratio, and NaOAc quantity) resulted with good isomer ratio of over 8:1 with respect to desired C-2 isomer 4 with minimum of di-substituted impurity 6. The crude product was, however, contaminated with Zn-based inorganics and had to be recrystallized to achieve acceptable purity and assay. Interaction of process variables and their corresponding effects on the percent conversion of maleic acid were discussed. Consistency of statistical model was verified by analysis of variance (ANOVA). API quality specifications (purity, impurity levels) are described across the modelling of process space, which was defined through quality target specifications (conversion NLT 70 %; Product Compound 4 NLT 50 %, Impurity 5 NMT 20 %, and Impurity 6 NMT 0.5).http://silverstripe.fkit.hr/cabeq/assets/Uploads/02-2-18.pdforganic synthesisQuality by Design (QbD)statistical DoE |
| spellingShingle | S. Kapić I. Nekola F. Jović M. Mihovilović Process Optimization and DOE Application in the Synthesis of Rociletinib Intermediate Chemical and Biochemical Engineering Quarterly organic synthesis Quality by Design (QbD) statistical DoE |
| title | Process Optimization and DOE Application in the Synthesis of Rociletinib Intermediate |
| title_full | Process Optimization and DOE Application in the Synthesis of Rociletinib Intermediate |
| title_fullStr | Process Optimization and DOE Application in the Synthesis of Rociletinib Intermediate |
| title_full_unstemmed | Process Optimization and DOE Application in the Synthesis of Rociletinib Intermediate |
| title_short | Process Optimization and DOE Application in the Synthesis of Rociletinib Intermediate |
| title_sort | process optimization and doe application in the synthesis of rociletinib intermediate |
| topic | organic synthesis Quality by Design (QbD) statistical DoE |
| url | http://silverstripe.fkit.hr/cabeq/assets/Uploads/02-2-18.pdf |
| work_keys_str_mv | AT skapic processoptimizationanddoeapplicationinthesynthesisofrociletinibintermediate AT inekola processoptimizationanddoeapplicationinthesynthesisofrociletinibintermediate AT fjovic processoptimizationanddoeapplicationinthesynthesisofrociletinibintermediate AT mmihovilovic processoptimizationanddoeapplicationinthesynthesisofrociletinibintermediate |